A Refreshing Outlook -- Consensus Reports on Cell Therapeutics, Inc. and Novartis AG
(firmenpresse) - JAKARTA, INDONESIA -- (Marketwire) -- 09/13/12 -- Moments ago, introduced new coverage of Cell Therapeutics, Inc. (NASDAQ: CTIC) and Novartis AG (NYSE: NVS). Full outlook, analysis and consensus opinion is available to readers via the links below.
The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include August's contraction of U.S. manufacturing activity, an upward surprise of 0.4% in seasonally-adjusted house prices and the unexpected decline in construction spending. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox.
Investors Alliance is releasing new coverage on Cell Therapeutics, Inc. for its current position within the consumer durables sector. Cell Therapeutics, Inc. (CTI) develops, acquires and commercializes treatments for cancer. The Company's research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. A copy of this report featuring Cell Therapeutics, Inc. (NASDAQ: CTIC) is available at: .
Investors Alliance has released research on Novartis AG for its changing role within the consumer durables sector. Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. To access the full research report on Novartis AG (NYSE: NVS) we welcome investors to visit: .
What is Investors Alliance?
Imagine a community wherein investors and traders of all walks share both knowledge and experience... enabling a knowledge base vastly greater than the sum of its parts. By joining forces, the entire community experiences the wealth of information, insight and intuition into some of the best strategies available today.
Patricia Byers
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.09.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 183116
Anzahl Zeichen: 2840
contact information:
Town:
JAKARTA, INDONESIA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 171 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"A Refreshing Outlook -- Consensus Reports on Cell Therapeutics, Inc. and Novartis AG"
steht unter der journalistisch-redaktionellen Verantwortung von
Investors Alliance (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
